Rogawski D, Cao T, Ma Q, Roy-O'Reilly M, et al. Durable responses to trastuzumab deruxtecan in patients with leptomeningeal metastases from breast cancer with variable HER2 expression. J Neurooncol 2024;170:209-217.
PMID: 39073687